The inhibitory avoidance test optimized for discovery of cognitive enhancers

Behavior Research Methods

Volumn 41, Issue 3, 2009, Pages 805-811

  Detrait, Eric R A Y ^a   Hanon, Étienne ^a   Dardenne, Bertrand ^a   Lamberty, Yves ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE; SCOPOLAMINE; TACRINE;

ANIMAL; ARTICLE; AVOIDANCE BEHAVIOR; C57BL MOUSE; DRUG EFFECT; DRUG INTERACTION; DRUG SCREENING; INSTRUMENTATION; MALE; METHODOLOGY; MOUSE;

ANIMALS; AVOIDANCE LEARNING; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; INDANS; MALE; MICE; MICE, INBRED C57BL; NOOTROPIC AGENTS; PIPERIDINES; SCOPOLAMINE; TACRINE;

EID: 68949183447     PISSN: 1554351X     EISSN: None     Source Type: Journal    
DOI: 10.3758/BRM.41.3.805     Document Type: Article

References (25)

1. Balogh, S. A., & Wehner, J. M. (2003). Inbred mouse strain differences in the establishment of long-term fear memory. Behavioural Brain Research, 140, 97-106.
2. Banfi, S., Cornelli, U., Fonio, W., & Dorigotti, L. (1982). A screening method for substances potentially active on learning and memory. Journal of Pharmacological Methods, 8, 255-263.
3. Bartus, R. T., Dean, R. L., Goas, J. A., & Lippa, A. S. (1980). Age-related changes in passive avoidance retention: Modulation with dietary choline. Science, 209, 301-303.
4. Bohdanecký, Z., & Jarvik, M. E. (1967). Impairment of one-trial passive avoidance learning in mice by scopolamine, scopolamine methylbromide, and physostigmine. International Journal of Neuropharmacology, 6, 217-222.
5. Brunner, D., Nestler, E., & Leahy, E. (2002). In need of high-throughput behavioral systems. Drug Discovery Today, 7(18 Suppl.), S107-S112.
6. Castellano, C., & Puglisi-Allegra, S. (1983). Strain-dependent modulation of memory by stress in mice. Behavioral & Neural Biology, 38, 133-138.
7. Caulfield, M. P. (1993). Muscarinic receptors-Characterization, coupling and function. Pharmacology & Therapeutics, 58, 319-379.
8. Crawley, J. N., Belknap, J. K., Collins, A., Crabbe, J. C., Frankel, W., Henderson, N., et al. (1997). Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies. Psychopharmacology, 132, 107-124.
9. Dawson, G. R., & Iversen, S. D. (1993). The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behavioural Brain Research, 57, 143-153.
10. Dilts, S. L., & Berry, C. A. (1967). Effect of cholinergic drugs on passive avoidance in the mouse. Journal of Pharmacology & Experimental Therapeutics, 158, 279-285.
11. Ebert, U., & Kirch, W. (1998). Scopolamine model of dementia: Electroencephalogram findings and cognitive performance. European Journal of Clinical Investigation, 28, 944-949.
12. Elrod, K., & Buccafusco, J. J. (1988). An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmacology, Biochemistry, & Behavior, 29, 15-21.
13. Graham, J. H., & Buccafusco, J. J. (2001). Inhibitory avoidance behavior and memory assessment. In J. J. Buccafusco (Ed.), Methods of behavior analysis in neuroscience (pp. 141-151). London: CCR.
14. Jarvik, M. E., & Kopp, R. (1967). An improved one-trial passive avoidance learning situation. Psychological Reports, 21, 221-224.
15. Kallman, M. J., & Condie, L. W., Jr. (1985). A test battery for screening behavioral teratogens in mice. Neurobehavioral Toxicology & Teratology, 7, 727-731.
16. Koide, T., Moriwaki, K., Ikeda, K., Niki, H., & Shiroishi, T. (2000). Multi-phenotype behavioral characterization of inbred strains derived from wild stocks of Mus musculus. Mammalian Genome, 8, 664-670.
17. Lamberty, Y., & Gower, A. J. (1990). Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age. Physiology & Behavior, 47, 1137-1144.
18. Pan, S. Y., Han, Y. F., Yu, Z. L., Yang, R., Dong, H., & Ko, K. M. (2006). Evaluation of acute tacrine treatment on passive-avoidance response, open-field behavior, and toxicity in 17- and 30-day-old mice. Pharmacology, Biochemistry, & Behavior, 85, 50-56.
19. Ray, D., & Nagy, Z. M. (1978). Emerging cholinergic mechanisms and ontogeny of response inhibition in the mouse. Journal of Comparative & Physiological Psychology, 92, 335-349.
20. Rush, D. (1988). Scopolamine amnesia of passive avoidance: A deficit of information acquisition. Behavioral & Neural Biology, 50, 255-274.
21. Sahgal, A. (1993). Passive avoidance procedures. In A. Shagal (Ed.), Behavioural neuroscience: A practical approach (Vol. 1, pp. 49-56). New York: Oxford University Press.
22. Sarter, M., Hagan, J., & Dudchenko, P. (1992). Behavioral screening for cognition enhancers: From indiscriminate to valid testing. Part II. Psychopharmacology, 107, 461-473.
23. Saxena, G., Singh, S. P., Agrawal, R., & Nath, C. (2008). Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. European Journal of Pharmacology, 581, 283-289.
24. Shutske, G. M., Pierrat, F. A., Kapples, K. J., Cornfeldt, M. L., Szewczak, M. R., Huger, F. P., et al. (1989). 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: Synthesis and evaluation as potential Alzheimer's disease therapeutics. Journal of Medicinal Chemistry, 32, 1805-1813.
25. Wehner, J. M., & Balogh, S. A. (2003). Phenotyping mice for learning and memory: Traditional tasks, modifications of traditional tasks, and application of new tasks [Society for Neuroscience, Short course].